Ventfort
- Category
- Bioregulators
- Administration routes
- Oral
- Regulatory status
- Not FDA-approved
What it is
A bioregulator peptide complex derived from blood vessel tissue, marketed to support vascular wall integrity and elasticity as vessels age. The case is speculative: claimed benefits for lipid profiles, atherosclerotic vessel function, and senile purpura rest on limited data, with only low-confidence signal on blood flow from related bioregulator work. Human safety data is thin. Not an approved drug in the US; supply is mostly research-grade product.
Read Full recordStudied uses & evidence
Studied uses(4)
Improved lipid profile (cholesterol, VLDL, triglycerides)
SpeculativeA small institute report describes human Ventfort results, but provides weak evidence.
Improved vascular wall function in atherosclerosis
SpeculativeCell and tissue-culture studies on the related KED tripeptide show vascular effects; no human data yet.
Improvement in senile purpura
SpeculativeA small institute report describes improved capillary resistance and fewer bleeding spots; reliable confirmation is lacking.
Evidence limits
- Evidence Level
- Limited Evidence
Ventfort has a formal clinical study with 49 patients showing improved lipid profiles and vascular function. The related synthetic peptide Vezugen has a PubMed-indexed study showing blood flow improvements. Together these provide modest supporting evidence, but studies are single-center, open-label, and have not been replicated outside Russia.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(2)
Risks = level of concern: High · Moderate · Low · Theoretical
Allergic reaction to bovine vascular-derived peptides
LowPotential interaction with anticoagulants
Theoretical
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.